期刊文献+

乌司他丁对脓毒症休克导致多器官功能衰竭的保护作用 被引量:17

Protective Effect of Ulinastatin on Various Organs in Septic Shock
下载PDF
导出
摘要 脓毒症休克主要与机体受到外界刺激后产生和释放的大量炎症因子有关,其本质是组织细胞缺血缺氧,临床治疗以抗炎和增加血管活性为主,但病死率仍较高。乌司他丁是从健康人体液中分离出的一种蛋白酶抑制剂,可抑制多种水解酶的活性,控制过度炎症反应,改善机体微循环状态,缓解器官由于缺血再灌注所导致的损伤,减少细胞凋亡,对脓毒症休克患者肺脏、心脏、肝脏、肾脏、脑、肠道及胰腺等器官均有一定保护作用,已广泛用于脓毒症休克的治疗。 Septic shock is mainly related to a large number of inflammatory factors produced and released by the body after being stimulated by the outside world.The essence of septic shock is ischemia and hypoxia of tissue cells.The main clinical treatment is anti-inflammatory and increase of vascular activity,but the mortality is still high.Ulinastatin is a protease inhibitor isolated from healthy human body fluid,which can inhibit the activity of many hydrolases,control excessive inflammatory reaction,improve the microcirculation state of the body,alleviate the injury of organs caused by ischemia reperfusion,and reduce cell apoptosis.Ulinastatin has a certain protective effect on the lung,heart,liver,kidney,brain,intestine,pancreas and other organs of the patients,and has been widely used in the treatment of septic shock.
作者 王韫文 赵敏 WANG Yunwen;ZHAO Min(Department of Emergency,Shengjing Hospital of China Medical University,Shenyang 110004,China)
出处 《医学综述》 2020年第1期101-106,共6页 Medical Recapitulate
基金 辽宁省自然科学基金(201602879)
关键词 脓毒症休克 乌司他丁 多器官功能衰竭 器官保护 Septic shock Ulinastatin Multiple organ failure Organ protection
  • 相关文献

参考文献3

二级参考文献33

  • 1班雨,沈洪,黎檀实.创伤感染致多器官功能障碍综合征大鼠炎症反应相关基因表达的变化及意义[J].中国危重病急救医学,2007,19(3):146-149. 被引量:2
  • 2李志军,李银平,盖慧荣,薛永来,冯喜增.脓毒症大鼠肝组织基因表达的研究[J].中国危重病急救医学,2007,19(3):156-159. 被引量:10
  • 3李志军,李银平,盖慧荣,胡顺鹏,王晓飞,薛永来,冯喜增.血必净注射液对脓毒症大鼠基因调控的影响[J].中国中西医结合急救杂志,2007,14(4):233-236. 被引量:10
  • 4Pittet J F,Morel D R,Hemsen A,et al.Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis[J].Ann Surg,1991,213(3):261-264.
  • 5Vieillard-Baron A,Caille V,Charron C,et al.Actual incidence of global left ventricular hypokinesia in adult septic shock[J].Crit Care Med,2008,36(6):1701-1706.
  • 6Wichterman K A,Bane A E,Chaudry I H.Sepsis and septic shock-a review of laboratory models and a proposal[J].J Surg Res,1980,29(2):189-201.
  • 7Favory R,Neviere R,Significance and interpretation of elevated troponin in septic patients[J].Crit Care,2006,10 (4):224.
  • 8Chopra M,Sharma A C.Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction[J].Life Sci,2007,81 (4):306-316.
  • 9Prabhu S D.Cytokine-induced modulation of cardiac function[J].Cire Res,2004,95(12):1140-1153.
  • 10Krivomchko I A,Boiko V V,Gusak I V,et al.The role of endothelin-1 in the pathogenesis of septic shock in the abdominal sepsis[J].Klin Khir,2004(1):30-33.

共引文献32

同被引文献175

引证文献17

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部